logo
#

Latest news with #PerformantHealthcare

PERFORMANT HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Performant Healthcare, Inc.
PERFORMANT HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Performant Healthcare, Inc.

Globe and Mail

time7 days ago

  • Business
  • Globe and Mail

PERFORMANT HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Performant Healthcare, Inc.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Performant Healthcare, Inc. (NasdaqGS: PHLT) to Machinify. Under the terms of the proposed transaction, shareholders of Performant will receive $7.75 in cash for each share of Performant that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, SNV, DALN on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, SNV, DALN on Behalf of Shareholders

Associated Press

time04-08-2025

  • Business
  • Associated Press

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, SNV, DALN on Behalf of Shareholders

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Performant Healthcare, Inc. (NASDAQ: PHLT)'s sale to Machinify for $7.75 in cash. If you are a Performant shareholder, click here to learn more about your legal rights and options. Synovus Financial Corp. (NYSE: SNV)'s merger with Pinnacle Financial Partners. Under the terms of the proposed transaction, the shares of Synovus and Pinnacle shareholders will be converted into shares of a new Pinnacle parent company based on a fixed exchange ratio of 0.5237 Synovus shares per Pinnacle share. Upon closing of the proposed transaction, Synovus shareholders will own approximately 48.5% of the combined company. If you are a Synovus shareholder, click here to learn more about your rights and options. DallasNews Corporation (NASDAQ: DALN)'s sale to Hearst for $14.00 in cash per share. If you are a DallasNews shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 [email protected] [email protected]

Machinify to acquire Performant Healthcare for $670m
Machinify to acquire Performant Healthcare for $670m

Yahoo

time04-08-2025

  • Business
  • Yahoo

Machinify to acquire Performant Healthcare for $670m

New Mountain Capital's portfolio company Machinify has signed a definitive agreement to acquire Performant Healthcare, a company in payment integrity, for around $670m. With the merger agreement, shareholders of Performant are set to receive $7.75 in cash for each outstanding share, a 139% premium over the 90-day volume-weighted average price of $3.25 as of 31 July 2025. New Mountain Capital Private Equity managing director and president Matt Holt said: 'The future of the US healthcare system requires modernisation of IT infrastructure, including patient-centric data networks. 'Performant plus Machinify plus the ecosystem of companies that we are building at New Mountain Capital will unlock the potential for a new system that is aligned with a more productive care model that is both more efficient and delivers better patient outcomes.' The acquisition is anticipated to be finalised by the end of this year, subject to closing conditions, encompassing approval from the shareholders of Performant and regulatory clearances. Machinify CEO David Pierre said: 'At Machinify, we are creating the modern, healthcare payments intelligence platform built for accuracy and transparency. 'By combining our powerful payer operating system with Performant's trusted domain expertise and differentiated data assets, Machinify will support a broader range of clients, including the Centers for Medicare and Medicaid, and state and local governments. The combined company will deliver quality, timely payments at dramatically reduced administrative costs.' Performant is required to maintain its business operations as usual until the transaction is completed. The company's board of directors has given unanimous approval for the deal. Pillsbury Winthrop Shaw Pittman is serving as legal counsel, while Truist Securities is providing exclusive financial advisory services to Performant. JP Morgan Securities is advising Machinify exclusively on financial aspects, with Ropes & Gray providing legal counsel. "Machinify to acquire Performant Healthcare for $670m" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Performant Healthcare Draws Buy Rating Despite Insider Sell-Off
Performant Healthcare Draws Buy Rating Despite Insider Sell-Off

Yahoo

time08-07-2025

  • Business
  • Yahoo

Performant Healthcare Draws Buy Rating Despite Insider Sell-Off

Performant Healthcare, Inc. (NASDAQ:PHLT) is one of the . Craig-Hallum maintains a Buy rating on the stock following a major stock sale by the company's top executive. A healthcare professional holding a device with innovative technology developed by the medical technology company. Headquartered in Florida, Performant Healthcare, Inc. (NASDAQ:PHLT) is a U.S.-based payment integrity company offering technology-enabled audit, recovery, eligibility, customer care, and analytics services to health plans. With solutions capable of identifying and recovering improper payments and streamlining billing processes, the company serves clients like Medicaid, Medicare Advantage, and commercial insurers. Performant Healthcare, Inc. (NASDAQ:PHLT) reported a 29% increase in revenue in Q1 2025, compared to the same quarter the previous year. The company has also revised its revenue guidance for 2025 from $133 to $135 million, signaling strong confidence in growth prospects. However, in a bold move, Director Lisa Im sold 180,867 shares of the company on June 4, 2025, in a transaction valued at $587,817. Amid this significant change in insider transactions, Craig-Hallum reiterated a Buy rating on the stock, indicating confidence in the company's future growth. With a one-year median stock price forecast of $7, Performant Healthcare, Inc. (NASDAQ:PHLT)'s shares are available for interested investors at a price of $4 as of June 30, 2025. While we acknowledge the potential of PHLT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Low Risk Dividend Paying Stocks for June 2025 and Disclosure. None. Sign in to access your portfolio

Performant to Participate in B Riley Securities' 25 th Annual Institutional Investor Conference
Performant to Participate in B Riley Securities' 25 th Annual Institutional Investor Conference

Business Wire

time14-05-2025

  • Business
  • Business Wire

Performant to Participate in B Riley Securities' 25 th Annual Institutional Investor Conference

PLANTATION, Fla.--(BUSINESS WIRE)--Performant Healthcare, Inc. (Nasdaq: PHLT) ('Performant'), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the B Riley Securities 25 th Annual Institutional Investor Conference on Wednesday May 21 st: will participate in one-on-one meetings to discuss the company's recently increased guidance and continued momentum in the commercial market Share Performant's Chief Financial Officer, Rohit Ramchandani, will participate in one-on-one meetings to discuss the company's recently increased guidance, continued momentum in the commercial market, and the potential impact of policy shifts under the new administration. To schedule a meeting, please contact Performant or your B Riley representative. ABOUT PERFORMANT Performant supports healthcare payers in identifying, preventing, and recovering waste and improper payments by leveraging advanced technology, analytics and proprietary data assets. Performant works with leading national and regional healthcare payers to provide eligibility-based, also known as coordination-of-benefits (COB) services, as well as claims-based services, which includes the audit and identification of improperly paid claims. Performant is a leading provider of these services in both government and commercial healthcare markets. Performant also provides advanced reporting capabilities, support services, customer care, and stakeholder training programs designed to mitigate future instances of improper payments. To learn more about Performant, please visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store